Invention Grant
- Patent Title: Cell-based composition and use thereof for treatment of diabetes and associated metabolic disorders and for amelioration of insulin resistance in pre-diabetes
-
Application No.: US16284177Application Date: 2019-02-25
-
Publication No.: US11052119B2Publication Date: 2021-07-06
- Inventor: Bernard Sze-Piaw Chin , Kong Yong Then , Soon Keng Cheong
- Applicant: Cytopeutics Sdn. Bhd.
- Applicant Address: MY Selangor
- Assignee: Cytopeutics Sdn. Bhd.
- Current Assignee: Cytopeutics Sdn. Bhd.
- Current Assignee Address: MY Selangor
- Agency: Cesari & McKenna, LLP
- Priority: MYPI2016701900 20160525
- Main IPC: A61K35/28
- IPC: A61K35/28 ; C12N5/0775
Abstract:
The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
Public/Granted literature
Information query
IPC分类:
